VDAC1 Influences Disulfidptosis and Immune Environment in Lung Adenocarcinoma

This study investigates the role of VDAC1 in lung adenocarcinoma (LUAD), focusing on its regulation of glucose-deprivation-induced disulfidptosis and its association with the tumor immune microenvironment. Using multi-omics data and validation through immunohistochemistry and functional assays, the research highlights VDAC1's potential as a biomarker and therapeutic target in LUAD. The findings address the challenges of tumor heterogeneity and therapy resistance in this common lung cancer subtype.

Originally published by gnews